Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 6/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 4/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.31 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.31 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3519177 | 0.94 | CA2 (0.49) | CA2NFKB1CYP3A4TSHRNPSR1 | |
| SCHEMBL11878759 | 0.92 | CA2 (0.55) | CA2NFKB1CYP3A4TSHRNPSR1 | |
| SCHEMBL9247328 | 0.89 | CA2 (0.59) | CA2NFKB1CYP3A4TSHRNPSR1 | |
| SCHEMBL11879863 | 0.89 | CA2 (0.59) | CA2NFKB1CYP3A4TSHRNPSR1 | |
| SCHEMBL9068224 | 0.89 | CA2 (0.59) | CA2NFKB1CYP3A4TSHRNPSR1 | |
| SCHEMBL7878112 | 0.87 | CA2 (0.62) | CA2NFKB1CYP3A4TSHRNPSR1 | |
| SCHEMBL8937003 | 0.87 | CA2 (0.62) | CA2NFKB1CYP3A4TSHRNPSR1 | |
| SCHEMBL6655133 | 0.87 | CA2 (0.62) | CA2NFKB1CYP3A4TSHRNPSR1 | |
| SCHEMBL4365094 | 0.87 | CA2 (0.62) | CA2NFKB1CYP3A4TSHRNPSR1 | |
| SCHEMBL27979198 | 0.84 | CA2 (0.46) | CA2NFKB1CYP3A4TSHRNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100190902-A1 | ALKYLTIN SULFANYL ESTER THIOLS | CHEMTURA CORPORATION (US) | 2010-07-29 | — | — | US | claimed |
| US-20100190902-A1 | ALKYLTIN SULFANYL ESTER THIOLS | CHEMTURA CORPORATION (US) | 2010-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100190902-A1 | ALKYLTIN SULFANYL ESTER THIOLS | SULT1E1, SULT1A1, TST | CA2 4833/4885NFKB1 3819/4885CYP3A4 1249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.